Robert Lorne Hopfner, Director, Ten Percent Owner at Evommune, Inc., holds 3.37M shares in Evommune, Inc. (Ticker: EVMN), holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX), holds 0.00 shares in Inozyme Pharma (Ticker: INZY). Most recently, Robert Lorne Hopfner Bought ― shares of Evommune, Inc. on Dec 22, 2025 for an estimated value of $17.35K.
What is the percentage of profitable transactions made by Robert Lorne Hopfner?
The percentage of profitable transactions made by Robert Lorne Hopfner is 44%.
What is the average return per transaction made by Robert Lorne Hopfner?
The average return per transaction made by Robert Lorne Hopfner is 2.70%.
What stocks does Robert Lorne Hopfner hold?
Robert Lorne Hopfner holds: EVMN, HPTX, PCVX, INZY, RLYB stocks.
What was Robert Lorne Hopfner’s latest transaction?
Robert Lorne Hopfner latest transaction was an Informative Buy of $17.35K.
What was Robert Lorne Hopfner's most profitable transaction?
Robert Lorne Hopfner’s most profitable transaction was an Informative Buy of INZY stock on March 30, 2023. The return on the trade was 63.30%.
What is Robert Lorne Hopfner's role in Evommune, Inc.?
Robert Lorne Hopfner's role in Evommune, Inc. is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.